The Manulife Asia Best Select Equity Fund lets you invest in a hand-picked selection of Asia's leading companies using Philippine pesos. Here's what it holds, who it suits, and how to invest through DragonFi.
It's an equity UITF (Unit Investment Trust Fund, a pooled fund run by a trust company). Unlike most of DragonFi's other global funds, it is not a feeder fund. Instead, it is directly managed by Manulife's investment team in Hong Kong, who pick individual companies across Asia. It is managed by Manulife.
What does it invest in?
The fund invests in a focused selection of leading companies across Asia, excluding Japan, covering markets such as China, Hong Kong, Taiwan, South Korea, Singapore, India, and the Philippines. The team uses a bottom-up approach, choosing market leaders with strong growth prospects and reasonable valuations rather than tracking an index. Its performance is measured against the MSCI Asia ex Japan Index. As of mid-2026, its largest holdings included major Asian companies such as Taiwan Semiconductor (TSMC), Samsung Electronics, SK hynix, Tencent, and Alibaba. For the current, full breakdown, see the fund's page in the DragonFi app.
Who is this fund for?
This fund may suit you if you:
- Want exposure to Asia's leading companies in a single fund
- Prefer an actively managed, hand-picked portfolio over an index
- Are comfortable with the ups and downs of the stock market
- Are investing for the long term, ideally more than five years
What's the risk level?
This is an aggressive-risk fund, the highest of the three risk bands. As a stock fund spanning emerging and developed Asian markets, its value can swing significantly, and because the underlying investments are in foreign currencies, exchange rate movements also affect your returns. In exchange, it offers high long-term growth potential. Returns are not guaranteed.
Can I hold this in a PERA or Regular account?
This fund is available through a Regular DragonFi account. It is not one of DragonFi's PERA-eligible funds.
What are the fees?
Like all UITFs, this fund charges a 1.75% per annum trust fee, already deducted from the fund before the daily price is calculated, so you don't pay it separately. Fees can change over time, so for the exact current trust fee, check this fund's page in the DragonFi app.
What's the minimum investment?
You can start investing in this fund for as low as ₱1,000 on DragonFi, and you can add to it any time.
How do I invest in or add to this fund?
You can invest in or top up this fund directly in the DragonFi app in a few taps. For the full steps, the daily cut-off time, and how your buy-in price (NAVPU) is set, see the "How to invest in a fund" article by DragonFi. Because this fund invests in overseas markets, your order may be priced with a slight delay compared with local funds.
How do I sell or redeem it?
You can redeem some or all of your investment in the app whenever you like, with no fixed lock-in period. Because this fund invests in overseas markets, proceeds usually take a little longer to arrive than they would for a local fund, typically around six to seven banking days. For details, see the "How to sell or redeem a fund" article by DragonFi.
Where do I see the current NAVPU and returns?
The live price (NAVPU) and the latest returns are always shown on this fund's page in the DragonFi app. We don't list those figures here because they change every day, so the app is your most up-to-date source.
Good to know
- Directly managed, not a feeder. The Hong Kong-based team selects each company itself, so the portfolio reflects their convictions rather than an index.
- Currency moves matter. Because the underlying stocks are in foreign currencies, exchange rates can affect your returns.
Access the fund page here:
Manulife Asia Best Select Equity Fund | DragonFi
This fund is not a deposit and is not insured by the Philippine Deposit Insurance Corporation (PDIC). Returns are not guaranteed. The fund's price (NAVPU) can rise and fall, so you may get back less than you invested, and past performance is not indicative of future results.